Enfusion

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. It is a software-as-a-service firm that develops a platform to eliminate technology and information barriers, and simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset. The company was founded by Tarek Hammoud, Stephen M. Malherbe, Oleg Movchan, and Scott Werner in 2006 and is headquartered in Chicago, IL.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Enfusion reports robust Q4 earnings, eyes growth in new markets

Enfusion's Q4 2022 performance reflects financial strength and growth momentum, supported by revenue growth, client wins, and strategic guidance for 2023.
The company's strengths lie in its market positioning, regional focus, and commitment to innovation, while challenges include managing churn levels and scaling managed services profitably.
Opportunities in expanding into new markets, enhancing client relationships, and driving revenue growth through strategic initiatives position Enfusion for continued success and market leadership.
Overall, Enfusion's proactive approach to market dynamics, client services, and product development sets a solid foundation for sustained growth and value creation, aligning with investor expectations and industry trends.

Enfusion reports robust Q1 earnings, eyes growth amid market challenges

Enfusion's Q1 2023 Earnings Call highlighted strong financial performance, strategic partnerships, and a positive outlook for the year. Despite market challenges, the company remains resilient and focused on growth opportunities. Management's reaffirmation of guidance and optimism for the future reflect confidence in Enfusion's trajectory.

Enfusion reports strong Q2 earnings, eyes growth through strategic partnerships

Enfusion's Q2 performance showcased growth and profitability despite challenges. The company's strategic focus on efficiency, partnerships, and tailored pricing strategies bodes well for future expansion and revenue generation.

Enfusion reports robust Q3 performance and eyes sustainable 20% growth

Enfusion's Q3 performance showcased strong revenue growth, client additions, and global market expansion, with a focus on Portfolio WorkBench.
Confidence in reaffirmed guidance, positive organic growth trends, and strategic investments position Enfusion for sustained success.
Challenges include managing quarterly fluctuations, balancing investments for growth, and addressing strategic clarity in key areas.
Opportunities lie in leveraging product capabilities, targeted investments, ACV growth, and global market expansion for continued success.

Enfusion reports robust Q4 earnings, eyes growth through technology innovation

Enfusion's strong Q4 performance, focus on SaaS platform benefits, and strategic guidance for 2024 demonstrate a commitment to growth and innovation. The company's emphasis on client service, technology enhancements, and market opportunities positions them well for future success. Enfusion's Investor Day in Fort Lauderdale on March 19 will showcase their integrated investment technology platform and growth outlook.

Enfusion excels in Q1 performance, eyes growth through client focus

Enfusion's Q1 2024 performance showcased strong revenue growth, client wins, and margin expansion, driven by efficient client onboarding and product enhancements.
The company's strengths in client relationships, differentiated offerings, and strategic pricing position it well for future growth and value creation.
Challenges in client fee pressure, resource allocation, and evolving seasonality require strategic solutions, while opportunities in product enhancements and growth algorithm offer avenues for expansion.
Enfusion's commitment to delivering on promises, shareholder value creation, and differentiation underpin its optimistic outlook and focus on long-term success.

Enfusion reports robust Q2 earnings, eyes global expansion opportunities

Enfusion's Q2 performance reflects strong revenue growth, client acquisitions, and product innovation.
The company's resilience to market forces and global expansion efforts position it for continued success.
Challenges lie in maintaining growth momentum, deepening client relationships, and adapting to market dynamics.

Enfusion reports robust Q3 growth, eyes sustained expansion and innovation

Enfusion's Q3 2024 earnings call highlighted strong financial performance, client acquisitions, and product advancements. The company's tightened revenue and EBITDA guidance for 2024 reflects management's confidence in continued growth. Analyst inquiries centered on strategic alternatives, product innovations, and revenue drivers, indicating investor interest in Enfusion's future prospects.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. (NYSE: ENFN), a leading provider of cloud-native investment management software and services, today announced that it will report its third quarter fiscal year 2022 financial results after the U.S. financial markets close on Thursday, November 10, 2022.

Enfusion Announces Third Quarter 2022 Earnings Release Date

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service ("SaaS") solutions for hedge funds and asset managers, announced today that Apex Group, a global financial services provider, has selected the Enfusion platform to enhance the delivery of middle-office services to its global fund administration client base.

Apex Group Selects Enfusion Platform to Enhance Daily Middle-Office Services Offering

Globant

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--FTV Capital, a prominent growth equity investment firm, today announced its inclusion for the second consecutive year on Inc.'s annual Founder-Friendly Investors list honoring the private equity and venture capital firms with the best track records of success backing entrepreneurs. The recognition comes on the heels of several milestones for the firm, including the close of its largest fund at $2.3 billion in March 2022 and continued strong momentum ov

FTV Capital Named to Inc.'s Founder-Friendly Investors List for Second Consecutive Year

Building on 16 years of consecutive revenue growth, the investment will expand Patra's customer reach and capabilities while bringing streamlined processes and automation to insurance EL DORADO HILLS, Calif. , Sept. 13, 2022 /PRNewswire/ -- Patra Corporation , a leading technology-enabled services company for the insurance industry, today announced a $146 million growth investment as part of a recapitalization from FTV Capital, a sector-focused growth equity firm with nearly 25 years of experience investing in technology-enabled services.

Patra Secures $146 Million Growth Equity Investment from FTV Capital to Accelerate Efficiencies Across Insurance Value Chain

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Today, Enfusion ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, announced they have ranked #78 on the 2022 IDC FinTech Rankings. The 19th annual vendor rankings represent the leading hardware, software, and service providers to the global financial services industry. Rankings are based on the 2021 calendar year revenues attributed to financial services and FinTech industries. “We are extremely

Enfusion Ranked 78th on Prestigious IDC FinTech Rankings

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-based investment management software and services, today announced that its Board of Directors (the “Board”) has appointed Oleg Movchan, currently a member of the Board, as Interim Chief Executive Officer, effective August 21, 2022. Mr. Movchan succeeds Thomas Kim, who has resigned as CEO and as a Director of the Company so that he can spend more time with his family. Mr. Movcha

Enfusion Appoints Oleg Movchan Interim Chief Executive Officer

Enfusion, Inc. (NYSE:ENFN ) Q2 2022 Results Conference Call August 9, 2022 5:00 PM ET Company Participants Ignatius Njoku - Head, IR Thomas Kim - CEO Steve Dorton - CFO Conference Call Participants Matthew Kicker - Stifel Tanaka Mehta - Bank of America James Faucette - Morgan Stanley Faith Brunner - William Blair Operator Good afternoon, ladies and gentlemen. Thank you for standing by.

Enfusion, Inc. (ENFN) CEO Thomas Kim on Q2 2022 Results - Earnings Call Transcript

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. (NYSE: ENFN), a leading provider of cloud-based investment management software and services, today announced financial results for the second quarter ended June 30, 2022. “We are very pleased with our second quarter performance, exceeding both revenue and profitability expectations,” said Thomas Kim, Chief Executive Officer, Enfusion. “We continue to sign larger deals, including a seven-figure deal, and added nine institutional asse

Enfusion Announces Second Quarter 2022 Results

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: ENFUSION CONTINUES TO EXPAND INTO NEW CLIENT SEGMENTS THROUGH THE LAUNCH OF ENFUSION EXPRESS OEMS - Broadens distribution through new Prime Broker and Outsourced Trading Desk partnerships - - Cowen and Company, LLC (“Cowen”) named the first partner to offer Enfusion Express to its client base - Enfusion, Inc. ("Enfusion") (NYSE: EN

CORRECTING and REPLACING Enfusion Continues to Expand into New Client Segments Through the Launch of Enfusion Express OEMS

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, today announced the launch of Enfusion Express, a lightweight yet institutional-grade SaaS order and execution management system (OEMS) tailored specifically to the needs of smaller fund managers with less than $100 million in AUM. The solution enables Enfusion to extend its technology to a global and growing market segment not prev

Enfusion Expands Into New Client Segment Through the Launch of Enfusion Express

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (“SaaS”) solutions for investment managers, today announced that it will report its second quarter fiscal year 2022 financial results after the U.S. financial markets close on Tuesday, August 9, 2022. Webcast and Conference Call Details In conjunction with this announcement, Enfusion will host a conference call at 2:00 PM (PT) / 5:00 PM (ET) on Tuesd

Enfusion Announces Second Quarter 2022 Earnings Release Date

NEW YORK--(BUSINESS WIRE)-- #finance--DataArt, a global software engineering firm, today announced that it has secured a $75 million minority growth investment from FTV Capital, a leading growth equity investment firm with over two decades of experience in enterprise technology. This investment, which closed earlier this year, follows a year of extraordinary growth in 2021 and 2022 year-to-date, as DataArt expanded its international footprint, strengthened its service offerings in key innovation sectors a

DataArt Secures $75 Million Growth Investment from FTV Capital to Further Expand Global Reach

Enfusion is down over 60% since its IPO last year. The company is aiming to disrupt the legacy investment management market with its revamped purpose-built solution.

Enfusion: A Compelling Financial SaaS Company

BOSTON--(BUSINESS WIRE)--Zoovu, an AI-powered discovery experience platform for B2B and B2C e-commerce, has raised $169 million led by FTV Capital.

Zoovu Secures $169 Million Series C Led by FTV Capital to Deliver Data-driven Product Discovery Experiences for E-commerce

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, released more than 100 enhancements and new features for its Order and Execution Management System (OEMS) in Q1 2022, as the asset management community increasingly shifts towards solutions that address the complexities associated with managing sophisticated daily order flow. Asset managers globally are faced with fee compression, m

Enfusion Launches New Features to Address Emerging OEMS Adoption Across Asset Management Industry

Enfusion, Inc. (NYSE:ENFN ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Ignatius Njoku - Head, IR Thomas Kim - CEO Steve Dorton - CFO Conference Call Participants Dylan Becker - William Blair Matthew Kikkert - Stifel Tanika Mehra - Bank of America Gabriela Borges - Goldman Sachs Chris Donat - Piper Sandler James Faucette - Morgan Stanley Operator Good afternoon. Thank you for attending today's Enfusion First Quarter Fiscal Year 2022 Earnings Call.

Enfusion, Inc. (ENFN) CEO Thomas Kim on Q1 2022 Earnings Call Transcript

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-based investment management software and services, today announced financial results for the first quarter ended March 31, 2022. “We continue to deliver revenue ahead of our expectations, driven by solid execution and broad adoption across all of our cloud native and managed services offerings,” said Thomas Kim, Chief Executive Officer, Enfusion. “The strong results give us conf

Enfusion Announces First Quarter 2022 Results

Northern Trust

CHICAGO--(BUSINESS WIRE)-- #assetmanagement--As part of its continuing strategy to serve client needs across the entire investment lifecycle, Northern Trust (Nasdaq: NTRS) has established a relationship with Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of cloud-native investment management software and services, to provide portfolio management, order and execution management system (OEMS), and analytics capabilities to mutual clients. Through this collaboration, Enfusion and Northern Trust offer a

Northern Trust Announces Alliance with Enfusion as Part of Whole Office Strategy

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of cloud-native investment management software and services, today announced that Enfusion's Chief Executive Officer, Thomas Kim, and Chief Financial Officer, Steve Dorton, will participate at the following investor events: William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022 Bank of America 2022 Global Technology Conference on Wednesday, June 8, 2022 Morgan Stanley

Enfusion to Present at Upcoming Investor Events

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of cloud-native investment management software and services, today announced that it will report its first quarter fiscal year 2022 financial results after the U.S. financial markets close on Thursday, May 12, 2022. Webcast and Conference Call Details In conjunction with this announcement, Enfusion will host a conference call at 2:00 PM (PT) / 5:00 PM (ET) on Thursday, May 12, 2022, duri

Enfusion Announces First Quarter 2022 Earnings Release Date

Investors weren't happy with the company's fourth-quarter loss.

Why Enfusion Stock Is Plummeting Today

Enfusion, Inc. (ENFN) CEO Thomas Kim on Q4 2021 Results - Earnings Call Transcript

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-based investment management software and services, today announced financial results for the fourth quarter and year ended December 31, 2021. “We finished the year on a strong note, with growth across all our products and services” said Thomas Kim, Chief Executive Officer, Enfusion. “Our results validate our continued high growth and quality profitability. I'm especially pleased

Enfusion Announces Fourth Quarter and Full Year 2021 Results

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. (NYSE: ENFN), a leading provider of cloud-native investment management software and services, today announced that it will report its fourth quarter fiscal year 2021 financial results after the U.S. financial markets close on Thursday, March 24, 2022. Webcast and Conference Call Details In conjunction with this announcement, Enfusion will host a conference call at 2:00 PM (PT) / 5:00 PM (ET) on Thursday, March 24, 2022 during which

Enfusion Announces Fourth Quarter 2021 Earnings Release Date

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native investment management software and services, today announced that founder Tarek Hammoud is retiring and will step down as a member of Enfusion's Board of Directors. “Tarek has been a great partner in making Enfusion what it is today, and we would not have accomplished the things that we have without his vision, talent, focus, and energy,” said Thomas Kim, Chief Executive

News for Enfusion Stock (ENFN)